
Imiquimod
Imiquimod is an imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. It has a role as an antineoplastic agent and an interferon inducer. — ChEBI
- IUPAC name
- 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
- Molecular formula
- C14H16N4
- Molecular weight
- 240.30 g/mol
- Exact mass
- 240.137496527 Da
- XLogP3
- 2.6
- Topological polar surface area
- 56.7 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:36704
- ChEMBL:CHEMBL1282
- EPA DTXSID:DTXSID7041047
- PubMed:41242269
- PubMed:40568777
- PubMed:40118199
- PubMed:38948922
- PubMed:38760990
- PubMed:36908085
- PubMed:36577999
- PubMed:36002070
- PubMed:34740670
- PubMed:32679548
- PubMed:32020584
- PubMed:31383729
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.